Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess

Recruiting

Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess

Sponsor:

University of Virginia

Code:

NCT01422759

Conditions

Obesity

Hyperandrogenemia

Polycystic Ovary Syndrome

Eligibility Criteria

Sex: Female

Age: 7 - 18

Healthy Volunteers: Not accepted

Interventions

Spironolactone

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by University of Virginia on 2023-10-27.